Boccia, R., Cooper, N., Ghanima, W., Boxer, M. A., Hill, Q. A., Sholzberg, M., . . . Bussel, J. B. (2020). Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia. Br J Haematol.
Styl cytowania ChicagoBoccia, Ralph, et al. "Fostamatinib Is an Effective Second‐line Therapy in Patients With Immune Thrombocytopenia." Br J Haematol 2020.
Styl cytowania MLABoccia, Ralph, et al. "Fostamatinib Is an Effective Second‐line Therapy in Patients With Immune Thrombocytopenia." Br J Haematol 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..